Migration through physical constraints is enabled by MAPK-induced cell softening via actin cytoskeleton re-organization by Rudzka, Dominika A. et al.
RESEARCH ARTICLE
Migration through physical constraints is enabled by MAPK-
induced cell softening via actin cytoskeleton re-organization
Dominika A. Rudzka1, Giulia Spennati2, David J. McGarry1, Ya-Hua Chim2, Matthew Neilson1,
Aleksandra Ptak1, June Munro1, Gabriela Kalna1,*, Ann Hedley1, Daniela Moralli3, Catherine Green3,
Susan Mason1, Karen Blyth1, Margaret Mullin4, Huabing Yin2 and Michael F. Olson1,5,‡,§
ABSTRACT
Cancer cells are softer than the normal cells, and metastatic cells are
even softer. These changes in biomechanical properties contribute to
cancer progression by facilitating cell movement through physically
constrainingenvironments. To identify properties that enabled passage
through physical constraints, cells that were more efficient at moving
through narrow membrane micropores were selected from established
cell lines. By examining micropore-selected human MDA MB 231
breast cancer and MDA MB 435 melanoma cancer cells, membrane
fluidity and nuclear elasticity were excluded as primary contributors.
Instead, reduced actin cytoskeleton anisotropy, focal adhesion density
and cell stiffnesswere characteristics associatedwith efficient passage
through constraints. By comparing transcriptomic profiles between the
parental and selected populations, increased Ras/MAPK signalling
was linked with cytoskeleton rearrangements and cell softening. MEK
inhibitor treatment reversed the transcriptional, cytoskeleton, focal
adhesion and elasticity changes. Conversely, expression of oncogenic
KRas in parental MDA MB 231 cells, or oncogenic BRaf in parental
MDA MB 435 cells, significantly reduced cell stiffness. These results
reveal that MAPK signalling, in addition to tumour cell proliferation, has
a significant role in regulating cell biomechanics.
This article has anassociatedFirst Person interviewwith the first author
of the paper.
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INTRODUCTION
The metastatic spread of cancer cells from primary tumours to distant
sites is the leading cause of cancer mortality, contributing to as much
as 90% of cancer-related deaths (Chaffer andWeinberg, 2011; Sporn,
1996). The life-threatening aspects of some cancers, including breast
cancers and melanoma, derive from the harm caused at distant
essential sites, including lung, liver, bones and brain, rather than at
their tissue of origin (Luke et al., 2017; Melzer et al., 2017).
Tumour cells passing through barriers (e.g. basement membrane,
tumour stroma and endothelial layers) encountered during metastasis
experience varying forms of physical confinement. Spaces in three-
dimensional (3D) extracellular matrix (ECM) create pores or tunnel-
like tracks, which often may be smaller than metastasizing cells
(Doerschuk et al., 1993;Weigelin et al., 2012). These pores and tracks
exist in healthy tissues; for example, they occur along or within blood
vessels (Lugassy et al., 2014), between muscle and nerve fibres
(Weigelin et al., 2012), between collagen fibres (Gritsenko et al.,
2012), or within brain perivascular spaces (Charles and Holland,
2010). Gaps may also be created or expanded by tumour-associated
stromal cells, which play active roles in enabling tumour cell spread
(Erdogan andWebb, 2017;Nielsen and Schmid, 2017). Processes that
increase aperture size can facilitate cell passage through narrow gaps.
For example, ECM degradation by enzymes, such as matrix
metalloproteases, is a common mechanism to enable tumour cell
invasion (Paterson and Courtneidge, 2018). Physical force generated
by migrating cells can expand pores to allow passage (Chang et al.,
2017). However, these processes may not be appropriate in all
contexts, or may be inadequate to increase pore size sufficiently to
enable efficient movement through confined environments. As a
result, cell pliability to allow changes in shape that enable a cell to
squeeze through narrow physical constraints can also play a
considerable role in local tissue invasion and consequent metastasis
(Alibert et al., 2017).
Cancer cells are heterogeneous for many properties (Altschuler and
Wu, 2010), this diversity engenders adaptability to environmental
conditions and contributes to disease progression (Meacham and
Morrison, 2013). Although typically isolated as individual clones
from patient tumours, single-cell analytical approaches including
transcriptional analysis, mapping of chromatin organization and
high-content imaging (Litzenburger et al., 2017; Yin et al., 2013;
Zamanighomi et al., 2018), have revealed that, although they may
be homogenous for their underlying genetic alterations, established
tumour cell lines are actually heterogeneous for numerous
characteristics and behaviours. The imposition of selective pressures
can result in positive selection for advantageous properties from
dispersed distributions of specific parameters.
To identify, in an unbiased manner, the properties that enable
migration through confined spaces, MDA MB 231 human breast
cancer cells were selected (denoted Sel1, Sel2 etc.) from starting
parent (denoted Parent) cell populations by multiple rounds of
passage through 3-μm-diameter microporous membranes that
severely impede migration. The MDA MB 231 Parent and pore-
selected cells were then used for two comparisons. Firstly, by
relating the characteristics of Parent and pore-selected cells to cells
selected by flow sorting for small size, it was possible to determineReceived 20 August 2018; Accepted 25 April 2019
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which properties were specifically associated with passage through
small spaces, and eliminate those characteristics that were linked
specifically with small cell size. Secondly, by comparing those
properties that differed between Parent and pore-selected MDA MB
231 breast cancer cells with those that also differed between Parent and
pore-selected MDA MB 435 melanoma cells, shared factors that
enabled movement through narrow gaps were determined. Through
these comparisons, we concluded that although pore-selected cells
were small, size was not a primary determinant of confined migration,
nor were nuclei size or elasticity, which were linked with cell size but
not the ability to pass through small diameter pores. Instead, decreased
filamentous actin (F-actin) anisotropy, focal adhesion density and
cell stiffness were defining characteristics of pore-selected cells.
Transcriptomic analysis identified increased Ras/mitogen-activated
protein kinase (MAPK) signalling output in pore-selected cells, while
inhibition of the activity of the upstream activators of the MAPKs
ERK1 and ERK2 (ERK1/2, also known as MAPK3 and MAPK1,
respectively), the MEK1 andMEK2 proteins (hereafter MEK1/2, also
known as MAP2K1 and MAP2K2), reversed the decreased F-actin
anisotropy, focal adhesion density and cell stiffness. IncreasedMAPK
signalling in unselected Parental cells was sufficient to decrease cell
stiffness, indicating that Ras/MAPK signalling plays a significant role
in regulating cell biomechanical properties, in addition to its well
characterized and central contributions to proliferation. These findings
suggest that MAPK signalling output might contribute widely to
cancer metastasis, and that inhibition of MAPK signalling could have
broad clinical benefits by increasing metastatic cell stiffness to restrict
movement through confined environments.
RESULTS
Pore-selected cells have properties that enable invasion
To isolate cells with properties that enable passage through narrow
physical constraints, cells were plated in serum-free medium in
tissue culture inserts with microporous membranes (3 µm average
diameter pores) that severely restrict cell movement (Fig. 1A,B). By
collecting cells that had passed through the physical constraints to
the serum-containing medium below, and subjecting them to two
additional rounds of selection, three independent populations of
pore-selected (Sel2, Sel3 and Sel4) MDA MB 231 D3H2LN
luciferase (abbreviated MDA MB 231; Jenkins et al., 2005) breast
cancer, and MDA MB 435 melanoma (Sel1, Sel2 and Sel3), cells
were isolated. For comparison purposes, three rounds of flow
sorting were used to isolate three independent populations (FS1,
FS2 and FS3) of small diameter MDA MB 231 cells (Fig. S1A).
The distribution of suspended Sel or FS cell diameters were
similarly shifted towards smaller sizes relative to Parent cells
(Fig. 1C, left panel), which resulted in significantly smaller
(by 15%) mean cell volumes (Fig. 1C, middle panel; Fig. S1B).
Single-cell high-content imaging revealed that the two-dimensional
(2D) areas of Sel and FS isolates were both significantly smaller
(by ∼45%) than Parent MDA MB 231 cells (Fig. 1C, right panel;
Fig. S1C). However, the pore-selected Sel cells were significantly
more efficient (greater than two times) at migrating through 3 µm
pore tissue culture inserts than Parent or FS populations (Fig. 1D).
Similarly, the diameters of three independent populations (Sel1,
Sel2 and Sel3) of pore-selected MDA MB 435 cells were shifted
towards a smaller distribution relative to Parent cells (Fig. 1E, left
panel), which resulted in significantly smaller 3D volumes
(by ∼15%) than Parent cells (Fig. 1E, middle panel; Fig. S1D).
In addition, high-content imaging revealed that Sel populations had
a ∼30% reduction in 2D area relative to Parent MDA MB 435 cells
(Fig. 1E, right panel; Fig. S1E). Similar to the pore-selected MDA
MB 231 cells, the MDA MB 435 Sel isolates were significantly
more efficient (∼4.5 times) at moving through 3 µm pore tissue
culture inserts compared to Parent cells (Fig. 1F).
Single-cell random migration was tracked for the Parent, Sel
and FS populations over a 22 h period, which revealed that pore-
selected MDA MB 231 cells were ∼28% faster (Fig. 1G, left
panel; Fig. S2A,B), and travelled∼24% further (Fig. 1G, right panel;
Fig. S2C) than Parent or FS populations. Similarly, pore-selected
MDA MB 435 cells were ∼3.3 times faster (Fig. 1H, left panel;
Fig. S2D,E) and travelled ∼3.4 times further (Fig. 1H, left panel;
Fig. S2F) than Parent cells.
To determine whether the properties that facilitate migration
through narrow physical constraints would also contribute to 3D
extracellular matrix (ECM) invasion, the distances that individual
cells invaded through dense fibroblast-remodelled collagen
matrices towards serum-containing medium were determined
(Rath et al., 2017). The MDA MB 231 Sel isolates invaded
significantly further (by 25%) into collagen matrices than either
Parent or FS populations (Fig. 1I; Fig. S2G), which was paralleled
by the 50% greater distances invaded by Sel MDAMB 435 isolates
compared to Parent cells (Fig. 1J; Fig. S2H). Importantly,
proliferation of all selected populations did not differ significantly
relative to the starting Parent MDA MB 231 (Fig. S1F) or Parent
MDA MB 435 (Fig. S1G), indicating that the differences in
invasion were not influenced by cell number. These results indicate
that cells with properties that enable migration through narrow gaps
in synthetic membranes, as well as through dense collagen matrices,
can be isolated from established tumour cell lines.
Nuclear and membrane properties do not contribute to
confined migration
The nucleus, as the largest and stiffest organelle, has considerable
influence on cell migration through confined environments
(reviewed in Charras and Sahai, 2014). High-content imaging
revealed that the 2D nuclear areas of MDA MB 231 Sel and FS
populations were both similarly smaller (by ∼25%) than those for
Parent cells (Fig. 2A, left panel; Fig. S3A), while the volumes of
individual isolated Sel and FS nuclei were equivalently reduced by
∼25% (Fig. 2A, right panel; Fig. S3B). To characterize possible
contributors to smaller nuclei in Sel and FS populations,
chromosomes were counted by cytogenetic methods. Consistent
with previous reports (Crepin et al., 1990), Parent MDA MB 231
cells were hyperploid, with ∼68 chromosomes per cell (Fig. 2B,
left; Fig. S3C). In contrast, Sel and FS populations had ∼54
chromosomes per cell, corresponding to >80% of cells being near
diploid (46–55 chromosomes), compared to only∼40% for Parental
cells (Fig. 2B, right; Fig. S3D,E). Chromatin compaction in Parent,
Sel2 and FS1 populations were compared by using a fluorescence
lifetime imaging-fluorescence resonance energy transfer (FLIM-
FRET)-based method, in which energy transfer between histone
H2B proteins fused to GFP (donor fluorophore) or mCherry
(acceptor fluorophore), which decreases GFP fluorescence lifetime,
occurs when the proteins are within ∼10 nm of each other (Ller̀es
et al., 2009). Chromatin compaction changes were first validated in
Parent and Sel2 MDA MB 231 cells following 2-deoxyglucose
(2-DG) plus NaN3-induced ATP depletion (Visvanathan et al.,
2013) (Fig. S3F,G). Relative to the mean fluorescence lifetimes
determined for Parent MDA MB 231 cells, representative Sel2
and FS1 isolates had similarly decreased fluorescence lifetimes,
indicating comparable chromatin compaction (Fig. 2C). Since
nuclear mechanical properties, which have previously been shown
to affect migration in confined environments (McGregor et al.,
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Fig. 1. See next page for legend.
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2016), are influenced by chromatin compaction (Furusawa et al.,
2015), the elasticities (Young’s modulus) of isolated nuclei from
Parent, Sel2 and FS1 populations (Fig. 2D, left panel) were
measured by atomic force microscopy (AFM) (McPhee et al.,
2010). The elasticities of Sel2 and FS1 nuclei were significantly
increased relative to Parent MDA MB 231 nuclei (Fig. 2D, right
panel). These results show that nuclear size and mechanical
properties, associated with changes in chromosome number and
compaction, are not the dominant factors that enable pore-selected
cells to migrate more efficiently through narrow gaps. Nuclear size
and DNA content were instead directly proportional to cell size, in
agreement with previous observations (Gillooly et al., 2015; Levy
and Heald, 2012).
Changes inmembrane fluidity, due to factors includingmembrane
composition and microdomain organization, have been reported
to be associated with altered cancer cell migration (Edmond et al.,
2015; Sade et al., 2012; Zhao et al., 2016). To determine whether
there were differences in membrane fluidity that might enable pore-
selected cells to move more effectively in confined environments,
fluorescence recovery after photobleaching (FRAP) analysis
(Fig. 2E) was performed with MDA MB 231 Parent, Sel2 and FS1
isolates. By measuring the lateral diffusion of NBD-C6-
sphingomyelin into a discrete 3 µm diameter photobleached
regions (Fig. 2F, left panel), no significant differences in the time
for 50% recovery (t1/2; Fig. 2F, centre panel; Fig. S3H) or the
maximum extent of recovery (mobile fraction; Fig. 2F, right panel;
Fig. S3I) between the Parent, Sel2 or FS1 populations were detected,
indicating that altered membrane fluidity was not a property of cells
selected through pores or by flow sorting.
Pore-selected cells have altered cytoskeleton organization
and focal adhesion density, which is associated with
decreased stiffness
The organization of the F-actin cytoskeleton is a major factor
regulating cancer cell migration (Olson and Sahai, 2009) and
determining cell mechanical properties, with F-actin fibre
organization and focal adhesions both contributing to cell stiffness
(Gupta et al., 2016, 2015; McPhee et al., 2010). High-magnification
imaging of phalloidin-stained fixed cells revealed obvious
differences in F-actin structures, with pore-selected Sel MDA MB
231 cells (Fig. 3A) and Sel MDA MB 435 cells (Fig. 3B) having
fewer long and parallel filaments. To quantify these differences, total
internal reflectance microscopy (TIRF) was used to reveal F-actin
structures along a ∼0.2 µm plane at cell–substrate interfaces (Fig.
S4A,B), to eliminate possible effects of cell height differences. The
organization of F-actin filaments can be described as isotropic, when
there is a uniform distribution in all directions, or anisotropic, if the
organization is directional. The degree of F-actin bundling and cross-
linking into elongated structures, such as stress fibres, which are
typically parallel in orientation, can be quantified as an increase in
actin anisotropy. Importantly, actin filament cross-linking increases
cytoskeleton stiffness (Rajagopal et al., 2018); therefore, F-actin
anisotropy is proportional to stiffness. TIRF images were analysed
for F-actin anisotropy (Boudaoud et al., 2014), which revealed that
Sel MDA MB 231 isolates had a significantly reduced F-actin
anisotropy relative to Parent or FS populations (Fig. 3C). In addition,
these TIRF images were quantified for relative F-actin integrated
density, which takes into account fluorescence intensity and cell area
to reflect total F-actin levels, revealing that MDA MB 231 Sel
populations had significantly lower total F-actin that Parent cells
(Fig. 3D). Similar results were observed for Sel MDAMB 435 cells,
with significantly lower F-actin anisotropy (Fig. 3E) and total F-actin
levels (Fig. 3F).
Focal adhesions communicate external force inwards to modify
cytoskeleton structures, and are responsive to internal cytoskeleton-
derived contractile force (Bershadsky et al., 2003; Romer et al.,
2006). Since all cells were plated on identical substrates, focal
adhesion density is an independent indicator of cytoskeleton
organization. Accompanying these F-actin changes, there
were lower densities of focal adhesions as detected by
immunofluorescence imaging of phosphorylated focal adhesion
kinase (pFAK; FAK is also known as PTK2) in Sel MDA MB 231
cells (Fig. 3G, upper panels) and in Sel MDA MB 435 cells
(Fig. 3H, upper panels). Focal adhesions per cell were corrected for
cell area to generate focal adhesion density scores, which showed
that Sel MDA MB 231 isolates had significantly lower focal
adhesion densities (by ∼55%) relative to Parent or FS populations
(Fig. 3I; Fig. S4C).
The contribution of the F-actin cytoskeleton to cell stiffness was
validated for MDA MB 231 cells with the actin polymerization
inhibitor Cytochalasin D, which disrupted F-actin and decreased
cells stiffness as determined by AFM (Fig. S4E). The elasticities
(Young’s modulus) of Sel MDA MB 231 cells were significantly
less stiff than Parent or FS populations (Fig. 3J). Similar to the
reduced F-actin anisotropy (Fig. 3E) and total F-actin (Fig. 3F) in
Sel MDA MB 435 cells relative to Parent cells, there also were
Fig. 1. Small-diameter-pore selection enriches for invasive and
metastatic cell behaviours. (A) Schematic diagram of pore-selection
strategy. Cells (106) were placed in serum-free medium in 7.5 cm diameter
tissue culture inserts with microporous membranes (3 µm pore diameter), and
allowed to migrate for 5 days towards serum-containing medium below.
‘Successful’ cells were collected, expanded and re-plated twice more as
above. Three separate pore-selected (Sel) populations were isolated for each
cell line. (B) Transmission electron micrograph showing MDA MB 231 cells on
the membrane surface and extending downwards into 3 µm pores. Scale bar:
10 µm. (C) Left graph, MDA MB 231 Parent, three independent pore-selected
(Sel2, Sel3, Sel4) and three independent flow-sorted (FS1, FS2, FS3) mean
±s.d. cell diameter profiles for cells greater than 10 µm at 0.1 µm bins from
three replicates. Middle and right graphs, mean±s.e.m. cell volumes (Parent,
n=6; Sel and FS, n=10 replicates) and areas (Parent, n=9; Sel or FS, n=20–21
replicates). *P<0.05, **P<0.01, ****P<0.0001 (Kruskal–Wallis one-way
ANOVA and Dunn’s multiple comparisons test). (D) MDA MB 231 Parent, Sel
and FS relative (%, mean±s.e.m.) cell migration through 3 µm pore inserts was
assessed after 3 days (Parent, n=9; Sel and FS, n=16–18 replicates).
**P<0.01, ***P<0.001 (Kruskal–Wallis one-way ANOVA and Dunn’s multiple
comparisons test). (E) Left graph, MDA MB 435 Parent and three independent
pore-selected (Sel1, Sel2, Sel3) mean±s.d. cell diameter profiles for cells
greater than 10 µm at 0.1 bins from three replicates. Middle and right graphs,
mean±s.e.m. cell volumes (Parent, n=4; Sel, n=12 replicates) and areas
(Parent, n=3; Sel, n=9 replicates). ***P<0.001, ****P<0.0001 (Student’s t-test).
(F) MDA MB 435 Parent and Sel relative (%, mean±s.e.m.) cell migration
through 3 µm pore inserts was assessed after 3 days (left; Parent n=4, Sel n=8
replicates). ***P<0.001 (Student’s t-test). (G) MDAMB 231 Parent, Sel and FS
single-cell random migration was tracked for 22 h. Left graph; mean±s.e.m.
velocities. Right graph, mean±s.e.m. accumulated distance. Parent, n=7; Sel,
n=14; FS, n=11. *P<0.05, **P<0.01, ***P<0.001 (Kruskal–Wallis one-way
ANOVA and Dunn’s multiple comparisons test). (H) MDA MB 435 Parent and
Sel single-cell randommigration was tracked for 22 h. Left graph, mean±s.e.m.
velocities. Right graph, mean±s.e.m. accumulated distance. Parent, n=6; Sel,
n=18. ****P<0.0001 (Student’s t-test). (I) Single-cell invasion into fibroblast-
conditioned collagen matrices for MDA MB 231 cells. Scale bars: 100 µm.
Individual cell distances invaded from the upper collagen surfaces were
measured, andmean±s.e.m. distances from independent determinations were
plotted (Parent, n=28; Sel, n=45; FS, n=45 replicates). ***P<0.001,
****P<0.0001 (one-way ANOVA and Tukey’s multiple comparisons test). (J)
Single-cell invasion distances into fibroblast-conditioned collagen matrices for
MDA MB 435 cells. Scale bars: 100 µm. Mean±s.e.m. cell distances invaded
from independent determinations were plotted (Parent, n=15; Sel, n=18
replicates). ****P<0.0001 (Student’s t-test).
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significantly lower numbers of focal adhesion densities (by ∼40%)
(Fig. 3K; Fig. S4D) and significantly reduced cell stiffness
(Fig. 3L). These results demonstrate that F-actin organization and
levels, focal adhesion density and cell elasticity are inter-related
properties associated with the ability of pore-selected cells to
efficiently move through confined environments.
Pore-selected cells have elevated MAPK signalling as
revealed by RNA sequencing
Given that the properties of pore-selected and flow-sorted cells that
differentiated them from Parent MDA MB 231 or MDA MB 435
cells were stably maintained over time and multiple cell passages,
their differences in constrained migration abilities could be due to
Fig. 2. Pore migration is not enabled by nuclear or membrane properties. (A) Parent, Sel and FSMDAMB 231 mean±s.e.m. nuclear areas (left; Parent n=9,
Sel and FS, n=20–21 replicates) and nuclear volumes (right; Parent, n=120; Sel and FS, n=111–123;). **P<0.01, ****P<0.0001 (left, Kruskal–Wallis one-way
ANOVA and Dunn’s multiple comparisons test; right, one-way ANOVA and Tukey’s multiple comparisons test). (B) Cytogenetic determination (minimum 20 cells
per experiment) of mean±s.e.m. chromosome number (left; Parent, n=3; Sel and FS, n=3–6 replicates) and percentage of cells near diploidy (right; 46–55
chromosomes). (C) Differences in FRET fluorescence lifetimes for nuclei labelled with GFP–H2B and RFP–H2B for Parent (n=40), Sel2 (n=38) and FS1 (n=38)
MDA MB 231 cells. ***P<0.001 (Kruskal–Wallis one-way ANOVA and Dunn’s multiple comparisons test). (D) Scanning electron micrographs of isolated nuclei
from Parent, Sel and FS MDAMB 231 cells. Scale bars: 5 µm. The Young’s modulus was determined by AFM for isolated nuclei from Parent (n=60), Sel2 (n=61)
and FS1 (n=71) MDA MB 231 cells. **P<0.01 (one-way ANOVA and Tukey’s multiple comparisons test). (E) FRAP of NBD-C6-sphingomyelin in 3 µm diameter
regions at the indicated times. The arrows points to the bleached region. Scale bar: 5 µm. (F) FRAP traces (left) indicating normalized fluorescence intensity for
Parent (n=12 cells) and Sel2 (n=7 cells) MDAMB 231 cells at the indicated times. Times for 50% recovery (t1/2; centre graph; Parent, n=39, Sel and FS, n=42–43)
and mobile fraction (right graph). For all box plots, the box represents the 25–75th percentiles, and the median is indicated. The whiskers show the 5–95th
percentiles, and outliers are indicated.
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stable transcriptional differences between populations. RNA
sequencing (RNA-seq) was performed on polyA+-enriched RNA
from Parent MDA MB 231 cells, two pore-selected isolates (Sel2,
Sel3) and two flow-sorted isolates (FS1, FS2), as well as parental
MDA MB 435 cells and two pore-selected isolates (Sel1, Sel2), as
described in Rudzka et al. (2017). By comparing mRNA transcript
reads of Parent MDA MB 231 with pore-selected Sel1 and Sel2
cells, using a ±1.5 fold-change (FC) cut-off and a statistical
threshold of P<0.05, 1817 genes were differentially expressed
(Fig. 4A). Comparing pore-selected MDA MB 231 Sel1 and Sel2
cells with flow-sorted FS1 and FS2 cells revealed 1632 gene
expression differences (Fig. 4A). The overlap between the two
comparisons was comprised of 615 genes, which were independent
of differing cell and nucleus size but associated with constrained
migration ability (Fig. 4A). Using the same criteria of a ±1.5 FC cut-
off and statistical threshold of P<0.05, the number and magnitude of
Fig. 3. See next page for legend.
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gene expression differences between Parent and two pore-selected
Sel1 and Sel2 MDA MB 435 populations were even greater, with
10,876 differentially expressed genes (Fig. 4A). When compared
with the patterns of gene expression inMDAMB 231 Parent and Sel
populations, there were 214 genes that were consistently associated
with constrained migration ability (Fig. 4A), which we define as the
pore-invasion gene set. When the 615 gene set associated with pore-
invasion from MDA MB 231 cells was compared with 189
‘Oncogenic Signature’ gene sets using Gene Set Enrichment
Analysis (GSEA) (Subramanian et al., 2005), five of the six most
statistically significant gene sets were associated with oncogenic
KRas signalling (Fig. 4B, left panel). Similarly, when the 214 pore-
invasion gene set common to MDA MB 231 and MDA MB 435
cells was analysed by GSEA, five of the six most statistically
significant oncogenic signature gene sets were associated with
KRas signalling (Fig. 4B, right panel). In total, 49 individual genes
from the 214 pore-invasion gene set were associated with
statistically significant KRas, BRaf and/or MAPK-linked
oncogenic signature gene sets, of which 18 were expressed at
lower levels and 31 at higher levels in Sel2 and Sel3 populations
relative to Parent and flow-sorted FS1 and FS2 MDAMB 231 cells
(Fig. 4C, upper panel). The same patterns of up- and down-
regulated gene expression were observed when comparing pore-
selected Sel1 and Sel2 isolates with Parent MDA MB 435 cells
(Fig. 4C, lower panel). We verified that signalling via the MAPK
pathway could blocked by two structurally unrelated MEK
inhibitors with differing mechanisms of action, the allosteric
MEK1/2 inhibitor Trametinib (Grimaldi et al., 2017; Roskoski,
2017) and the non-competitive inhibitor U0126 (Favata et al.,
1998), in both MDA MB 231 and MDA MB 435 cells (Fig. 4D;
Fig. S5A). To test the dependence of the altered gene expression on
MAPK signalling, exemplar genes were selected for analysis [seven
upregulated genes (HBEGF, CFS2, ENPP1, PLAU, PLAT, PTPRU
and HSD11BA) and one downregulated gene (MXRA8)], based on a
sufficient number of sequence reads that would enable robust
quantification by quantitative RT-PCR (qPCR) following 24 h
treatment with vehicle DMSO or the allosteric MEK1/2 inhibitor
Trametinib (Grimaldi et al., 2017; Roskoski, 2017). The expression
of all seven upregulated genes identified by RNA-seq were
expressed >100%, and MXRA8 was <100%, in pore-selected Sel2
cells relative to Parent MDA MB 231 cells, and Trametinib
significantly reversed these expression patterns (Fig. 4E). Similarly,
the expression of six upregulated genes (HBEGF, CFS2, PLAU,
PLAT, PTPRU and HSD11BA) and one downregulated gene
(MXRA8) identified by RNA-seq were confirmed as being
correspondingly altered by qPCR, and significantly reversed by
Trametinib treatment in Sel1 MDA MB 435 cells (Fig. 4F).
To assess MAPK activation, MDA MB 231 Parent, Sel and FS
isolates were western blotted for active phosphorylated (pMEK1/2)
and total MEK1 and MEK2 (MEK1/2) (Fig. 5A, left panel). By
quantifying the relative intensities of near-infrared dye-conjugated
secondary antibody staining, it was determined that Sel populations
had significantly elevated ratio of active-to-total MEK1/2 indicating
increased MAPK signalling (Fig. 5A, right panel; Fig. S5B).
Similarly, the elevated ratio of active-to-total MEK1/2 was
significantly higher in MDA MB 435 Sel populations relative to
Parent cells (Fig. 5B; Fig. S5C). These results indicate that pore-
selected Sel isolates have relatively higher levels of basal MAPK
signalling. To determine whether pore-selection was likely to
have enriched for cells from theMDAMB 231 Parent population for
cells with pre-existing higher levels of MAPK signalling, the
frequency distributions of pMEK1/2 staining intensities were
plotted for >2800 single cells as determined by high-content
imaging. Compared to the frequency distribution for Parent cells
(Fig. 5C, grey line), there was a slight rightward shift for FS
populations and an even greater rightward shift for Sel populations
(Fig. 5C; FS cells, red lines; Sel cells, blue lines). When the median
pMEK1/2 intensities for Parent cells from three independent
experiments were used to determine the percentage of Sel and FS
cells with higher pMEK1/2 levels than 50% of Parent cells [1245
arbitrary units (A.U.)], the Sel populations had significantly more
cells with higher pMEK1/2 staining intensity than either Parent or
FS cells (Fig. 5D, left panel). Similarly, when the median values for
the three independent replicate experiments for the three Sel and FS
populations were compared to Parent cells (1245±42 A.U.), Sel
median pMEK1/2 levels were∼39% higher (1729±60 A.U.) and FS
median values were ∼21% higher (1508±76 A.U.). Importantly, the
Sel median pMEK1/2 staining intensities were significantly higher
than both Parent and FS populations (Fig. 5D, right panel). These
observations support the conclusion that pore-selection enriched for
cells with relatively higher MAPK signalling that pre-existed in the
Parent population, similar to the enrichment for pre-existing smaller
cells from the broader distribution of Parent cell sizes (Fig. 1C,E).
MAPK is necessary and sufficient for changes in elasticity
associated with invasion
The influence of MAPK signalling on F-actin cytoskeleton
structures, focal adhesions and cell elasticity was examined by
treating pore-selected cells with the MEK inhibitors Trametinib
(Roskoski, 2017) or U0126 (Favata et al., 1998). F-actin structures
were observably more extensive in pore-selected Sel2 MDA MB
231 cells following 0.5 µM Trametinib treatment (Fig. 6A, left
panel), which was reflected by significantly increased F-actin
anisotropy (Fig. 6A, middle panel) and greater F-actin staining
(Fig. 6A, right panel) as determined from images obtained by TIRF
microscopy (Fig. S6A). Similar observations were made following
Trametinib treatment of pore-selected Sel1 MDA MB 435 cells
(Fig. 6B, left panel; Fig. S6B), with increased F-actin anisotropy
Fig. 3. Decreased F-actin anisotropy and intensity, focal adhesion
density and Young’s modulus in pore-selected cells. (A) Parent, Sel and
FS MDA MB 231 cells were fixed and stained with phalloidin for F-actin. Scale
bars: 5 µm. (B) Parent and Sel MDA MB 435 cells were fixed and stained for
F-actin. Scale bars: 5 µm. (C) TIRF images of phalloidin-stained Parent, Sel
and FS MDA MB 231 cells were scored for F-actin anisotropy. Parent, n=59,
Sel and FS, n=138–145. **P<0.01, ***P<0.001 (one-way ANOVA and Tukey’s
multiple comparisons test). (D) Mean±s.e.m. relative F-actin integrated density
normalized to Parent levels (set at 100%). *P<0.05 (Kruskal–Wallis one-way
ANOVA and Dunn’s multiple comparisons test). (E) TIRF images of phalloidin-
stained Parent and Sel FS MDA MB 435 cells were scored for F-actin
anisotropy. Parent, n=88; Sel, n=78. ****P<0.0001 (Student’s t-test). (F) Mean
±s.e.m. relative F-actin integrated density normalized to Parent levels (set at
100%). **P<0.01 (Student’s t-test). (G) Parent, Sel and FS MDA MB 231 cells
were fixed and stained for pFAK to mark focal adhesions (upper panels) and
with phalloidin for F-actin (lower panel, overlay). Scale bars: 5 µm. (H) Parent
and Sel MDA MB 435 cells were fixed and stained for pFAK to mark focal
adhesions (upper panels) and with phalloidin for F-actin (lower panel, overlay).
Scale bars: 5 µm. (I) Mean±s.e.m. focal adhesion density (Parent, n=3, Sel
and FS, n=9 replicates). *P<0.05, **P<0.01, ***P<0.001 (Kruskal–Wallis one-
way ANOVA and Dunn’s multiple comparisons test). (J) Cell elasticity (Young’s
modulus) of Parent (n=87), Sel2 (n=88) and FS1 (n=79) MDA MB 231 cells.
***P<0.001, ****P<0.0001 (one-way ANOVA and Tukey’s multiple
comparisons test). (K) Mean±s.e.m. focal adhesion density (Parent, n=4; Sel,
n=6 replicates). *P<0.05 (Student’s t-test). (L) Young’s modulus of Parent
(n=160) and Sel1 (n=160) MDA MB 435 cells. ****P<0.0001 (Student’s t-test).
For all box plots, the box represents the 25–75th percentiles, and themedian is
indicated. The whiskers show the 5–95th percentiles, and outliers are
indicated.
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Fig. 4. See next page for legend.
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(Fig. 6B, middle panel) and greater F-actin staining (Fig. 6B, right
panel). The MEK inhibitor U0126 (10 µM) also resulted in changes
in actin cytoskeleton changes in both Sel2 MDAMB 231 cells (Fig.
S6C) and Sel1 MDA MB 435 cells (Fig. S6D), which resulted in
increased F-actin filament anisotropy and greater levels of F-actin
staining in both cell types (Fig. S6E,F). Treatment with 0.5 µM
Trametinib also significantly increased the pFAK-positive focal
adhesion density in Sel2 MDA MB 231 (Fig. 6C; Fig. S6G) and
Sel1 MDA MB 435 cells (Fig. 6D; Fig. S6H). Similar changes in
focal adhesion density were induced in both cell types by treatment
with 10 µMU0126 (Fig. S6I,J). The random single-cell velocities of
Sel2 MDA MB 231 cells were significantly reduced by 0.5 µM
Trametinib and 10 µM U0126 (Fig. 6E; Fig. S7A), as were the
velocities of Sel1 MDA MB 435 cells (Fig. 6F; Fig. S7B). In
parallel, the accumulated distances travelled by Sel2 MDAMB 231
(Fig. S7C) and Sel1MDAMB 435 cells (Fig. S7D) were reduced by
both Trametinib and U0126. The changes in F-actin organization
and focal adhesions induced by 0.5 µM Trametinib and 10 µM
U0126 were accompanied by significantly increased cell stiffness in
Sel2MDAMB 231 breast cancer cells (Fig. 6G) and Sel1MDAMB
435 melanoma cells (Fig. 6H). However, the diameters of Sel2
MDA MB 231 cells were not increased by 0.5 µM Trametinib
(Fig. 7A) or 10 µM U0126 (Fig. 7B), with similar observations of a
lack of effect on MDA MB 435 cells treated with Trametinib
(Fig. 7C) or U0126 (Fig. 7D). These results indicate that the
majority of the phenotypes enriched by passage through 3 µm
diameter pores that are associated with elevated MAPK activity
(i.e. changes in gene expression, actin cytoskeleton rearrangements,
decreases in focal adhesion density, increased motility and cell
softening) could be reversed by inhibition of MAPK signalling. The
exception was the selection for small diameter cells, which appears
to be an independent variable that likely also contributes to passage
through small physical constrictions.
Given that pore-selected cells showed evidence of increased
MAPK signalling (Fig. 5) and MEK inhibitor-induced cell
stiffening (Fig. 6G,H), one question was whether increased
MAPK signalling would be sufficient to decrease Parent cell
stiffness. Transfection and fluorescence-based sorting of Parent
MDAMB 231 cells expressing GFP or activated GFP–KRas G12D
(Fig. 7E, left panel) revealed significantly increased phosphorylated
ERK1/2 (pERK1/2) (Fig. 7E, left and right panels; Fig. S5D),
which was accompanied by reduced F-actin fibres, focal adhesion
density (Fig. 7F) and significantly decreased cell stiffness (Fig. 7G).
Similarly, transfection and sorting of Parent MDA MB 435 cells
with GFP or activated GFP–BRaf V600E (Hernandez et al., 2016)
(Fig. 7H, left panel) resulted in significantly increased pERK1/2
(Fig. 7H, left and right panels; Fig. S5E), which was accompanied
by reduced F-actin fibres, focal adhesion density (Fig. 7I) and a
significantly decreased cells stiffness (Fig. 7J). The greater
magnitude of ERK1/2 activation induced by GFP–BRaf V600E
expression in MDA MB 435 cells (Fig. 7H) relative to the GFP-
KRas G12D expression in MDA MB 231 cells (Fig. 7E) was
associated with a comparably larger decrease in cell stiffness
(Fig. 7G,J), consistent with a direct link between MAPK activation
and regulation of cell mechanical properties. These findings reveal
that the Ras/RAF-regulated MAPK pathway has a profound role in
the regulation of cancer cell biomechanics.
DISCUSSION
From a biomechanical perspective, cells have viscoelastic properties
that can deform if force is applied, and will recover their shape when
force is removed (Kuznetsova et al., 2007). Changes in cellular
mechanical properties have been observed in cancer, with tumour
cells being softer than normal cells, and highly metastatic cells
being more easily deformed than less metastatic cancer cells (Cross
et al., 2007; Faria et al., 2008; Hayashi and Iwata, 2015; Li et al.,
2008). These changes in mechanical properties have been proposed
to play important roles in several of the steps in the metastatic
process by increasing morphological plasticity to enable cells to
pass through physical constrictions (Cross et al., 2007, 2008).
The actin cytoskeleton plays important roles in defining cell shape,
driving migration and invasion, and is also a major factor affecting
cell mechanical properties (Li et al., 2008; Palmieri et al., 2015). The
main determinant of cell elasticity is the cortical cytoskeleton, the
dense actin–myosin meshwork that lies directly beneath the plasma
membrane (Bray and White, 1988; Salbreux et al., 2012). In addition
to the density and length of actin-myosin filaments, the organization
of cytoskeleton structures determines cell elasticity. Cells with well-
aligned anisotropic actin–myosin fibres are stiffer, while cells with
disorganized isotropic cytoskeleton structures are softer (Gupta et al.,
2015). In this study, RNA sequencing identified increased KRas/
MAPK signalling as a defining feature of pore-selected cells. Given
that MDAMB 231 breast cancer cells express activated G13D KRas
and moderately activated G464V BRaf (Davies et al., 2002), while
MDA MB 435 melanoma cells express oncogenic V600E BRaf,
increased KRas signal output was not the result of selection for cells
with de novo Ras/MAPK pathway mutations. Instead, pore-selection
enriched for cells with relatively higher Ras/MAPK signal output
from the dispersed distribution of activation levels that would be
present in the starting population. One question arising is whether
selection for elevated Ras/MAPK signal output is dependent on the
presence of activating Ras/MAPK mutations, or whether cells
transformed by other oncogenes would also be enriched for
elevated Ras/MAPK signalling to reduce cell stiffness when
subjected to narrow pore-selection. An additional question is if
acute Ras/MAPK activation during the migration of non-transformed
cells, such as following ligand stimulation, would be sufficient to
transiently reduce cell stiffness to enable migration through confined
Fig. 4. RNA sequencing reveals increased Ras/MAPK signal output in
pore-selected cells. (A) Venn diagram indicating number of shared changes
in gene expression (FC>1.5×; P<0.05) for MDA MB 231 Parent versus Sel
(light blue; 1817), MDA MB 231 FS versus Sel (dark blue; 1632) and MDA MB
435 Parent versus Sel (yellow; 10,876). The gene set associated with pore
selection, and not small size [(Parent versus Sel) versus (FS versus Sel)] for
MDAMB231 comprised 615 genes, of which 214were also altered inMDAMB
435 Parent versus Sel. (B) The most-significant GSEA ‘oncogenic signatures’
identified for the MDA MB 231 615 gene set (left) or 214 combined gene set
(right). (C) Relative expression of 49 genes from the 214 combined gene set
that were identified in GSEARAS/RAF/MEK-related ‘oncogenic signatures’. Z-
scores were calculated from number of RNA sequence reads in the
experimental replicates of Parent, Sel2, Sel3, FS1, FS2 MDA MB 231 cells
(upper panel) within the column for each gene. Similarly, gene expression was
compared by calculating Z-scores from the RNA sequences reads in the
experimental replicates for Parent, Sel1 and Sel2 MDA MB 435 cells (lower
panel). Green indicates relatively higher expression, red indicates relatively
lower expression. (D) Western blots of phosphorylated active ERK1/2 (pERK)
and total ERK1/2 (ERK) for MDA MB 231 Sel2 and MDA MB 435 Sel1
populations following treatment with DMSO vehicle, 0.5 µM Trametinib or
10 µMU0126 for 18 h. GAPDH is shown as a loading control. (E) Mean±s.e.m.
gene expression levels in the indicated Sel MDA MB 231 cells were
determined by qPCR relative to Parent cells (set at 100%) following treatment
with vehicle DMSO or 0.5 µM Trametinib (Tram) for 24 h. **P<0.01, ***P<0.001
between DMSO and Tram for each gene (Student’s t-test; n=9 replicates). (F)
Mean±s.e.m. relative gene expression in indicated Sel MDA MB 435 cells
following treatment with DMSO or 0.5 µM Trametinib (Tram) for 24 h. **P<0.01,
***P<0.001 (Student’s t-test; n=6–9 replicates).
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environments, as would occur, for example, during leukocyte
extravasation, or whether sustained Ras/MAPK signal output is
necessary to drive long-term adaptions, possibly mediated by
transcriptional responses that alter biomechanical properties.
Interestingly, we observed that pore-selected MDA MB 435
melanoma cells were proportionally more invasive through 3 µm
diameter pores (Fig. 1F) and fibroblast-conditioned collagen
(Fig. 1J) than their Parent cells when compared to the lesser
increase in invasiveness of pore-selected MDA MB 231 cells
relative to their Parent cells (Fig. 1D,I). However, the absolute
values for F-actin anisotropy (Fig. 3C,E), focal adhesion density
(Fig. 3I,K) and elasticity (Fig. 3J,L) were not greatly different
between the MDA MB 231 and MDA MB 435 pore-selected
populations, nor were the relative fold-change differences in F-actin
levels (Fig. 3D,F) or MEK phosphorylation (Fig. 5A,B). It is
important to note that the MDA MB 231-luc-D3H2LN clone used
in this study was previously selected in vivo for their ability to
spontaneously disseminate to lymph nodes from their mammary fat
pad site of injection (Jenkins et al., 2005). It is possible that the
in vivo selection had already enriched for some properties that
enabled efficient passage through narrow pores, such that there was
a lower potential for large increases in invasive behaviour compared
to what was possible for the MDA MB 435 cells, which had not
been previously selected. One such property is the velocity of cell
migration, which was approximately three times higher in Parent
MDAMB 231 cells than in Parent MDAMB 435 cells (Fig. 1G,H).
In addition, the greater number and magnitude of significantly
changed mRNA transcripts in pore-selected MDA MB 435 cells
relative to their Parent cells than for pore-selected MDA MB 231
cells compared to their Parent cells (Fig. 4A) suggests that the
melanoma cell line may have greater potential for increased
transcriptional responses, that collectively contribute to their
proportionally larger increase in movement through narrow
constraints.
The pore-selected cells were smaller in volume and two
dimensional area than the parent cells for both MDA MB 231 and
MDAMB 435 cells (Fig. 1C,E). By specifically selecting for small
diameter cells by flow sorting, additional independent populations
of small size MDAMB 231 cells were isolated, indicating that these
small size cells exist in the parental population independent of
the pore-selection. Indeed, the frequency distribution plots in
Fig. 1C,E support the conclusion that the small size pore-selected
and flow-sorted cells were selected from cells already present in the
parental populations.
The nucleus is the largest and stiffest organelle, and previous
studies have concluded that reduced nuclear stiffness is a major
Fig. 5. Elevated active MEK in pore-selected cells. (A) Left; western blots of phosphorylated active MEK1/2 (pMEK1/2) and total MEK1/2 (MEK1/2) for
MDAMB 231 Parent, Sel2, Sel3, Sel4, FS1, FS2 and FS3 populations. Right, graph of the mean±s.e.m. ratio of pMEK1/2 to total MEK1/2 relative to Parent MDA
MB 231 cells (set at 1). **P<0.01 (Kruskal–Wallis one-way ANOVA and Dunn’s multiple comparisons test; Parent, n=3; Sel and FS, n=9 replicates). (B) Left,
western blots of pMEK1/2 and MEK1/2 for Parent, Sel1, Sel2, and Sel3 populations. Right, Graph of the mean±s.e.m. ratio of pMEK1/2 to total MEK1/2
relative to Parent MDA MB 435 cells. **P<0.01 (Student’s t-test; Parent, n=3; Sel, n=9 replicates). (C) Frequency distribution of MDA MB 231 Parent, three
independent pore-selected (Sel2, Sel3 and Sel4) and three independent flow-sorted (FS1, FS2, FS3) of the mean pMEK1/2 single-cell fluorescence intensities at
250 arbitrary unit (A.U.) bins from three replicates. (D) Left graph, the mean±s.e.m. percentage of cells from the indicated Sel and FS populations with higher
levels of pMEK1/2 the mean of Parent median determined from three replicate determinations. Right graph; the mean of the median pMEK1/2 fluorescence
intensities of Parent cells from three replicate determinations was set 100%, and compared with the median pMEK1/2 for each replicate experiment for the cells
indicated. Parent, n=3; Sel, n=9; FS n=9 replicates. *P<0.05, **P<0.01, ***P<0.001 (Kruskal–Wallis one-way ANOVA and Dunn’s multiple comparisons test).
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determinant of confined migration (McGregor et al., 2016). Pore-
selection led to enrichment for small cell and nuclear size. However,
analysis of small cells isolated by flow-sorting revealed that nuclear
size was linked to cell size rather than the ability to undergo
confined migration. Small nuclei in both pore-selected and flow-
sorted isolates had fewer chromosomes, which were more
Fig. 6. See next page for legend.
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compacted, and were stiffer than the larger nuclei in Parent cells.
Given the strong link between cell and nucleus size (Edens et al.,
2013), pore-selection likely co-selected both properties in Sel
populations. Since equally small flow-sorted MDA MB 231 cells
were not better than Parent cells at passing through 3 µm pores,
small cell and nuclear size on their own are not sufficient to increase
migration through pores, thereby reinforcing the importance of
cytoskeleton-mediated elasticity and, by extension, the role of
MAPK signalling in regulating cell biomechanical properties.
These findings indicate that metastatic cancer cells benefit from
MAPK signalling by decreasing cell stiffness to enable movement
through confined environments, in addition to the significant role
that MAPK signalling plays in the regulation of proliferation.
MATERIALS AND METHODS
Cell culture
MDA MB 231-luc-D3H2LN and MDA MB 435 cell lines were grown in
HyClone MEM/EBSS medium (GE Healthcare Life Sciences, 11541871),
supplemented with 10% fetal bovine serum (FBS) (Gibco, 10270), 2 mML-
glutamine (Gibco, 25030-032), 10 U/ml penicillin and 10 µg/ml
streptomycin (Gibco, 15140-122), 1% MEM/NEAA (Thermo Fisher
Scientific, 11140035), 1% sodium pyruvate (Thermo Fisher Scientific,
11360070). Cell identities were validated by the Cancer Research UK
Beatson Institute Molecular Services using the GenePrint 10 system STR
multiplex assay (Promega), which amplifies nine tetranucleotide repeat loci
and the amelogenin gender-determining marker. Human fibroblasts were
kindly provided byMax Nobis (Cancer Research UKBeatson Institute), and
were grown in DMEM (Gibco, 21969-035) supplemented with 10% FBS,
2 mM L-glutamine, 10 U/ml penicillin and 10 µg/ml streptomycin. All cell
lines were routinely tested for mycoplasma by the Cancer Research UK
Beatson Institute Molecular Services.
Independent MDA MB 231 or MDA MB 435 pore-selected (Sel)
populations were established by seeding 106 cells in 10 ml serum-free
medium on 3 μm pore membranes in 7.5 cm cell culture inserts (Corning,
Thermo Fisher Scientific, 3420). Inserts were placed in 10 cm dishes
containing 10 ml serum-containing medium, and were left for 5 days in
standard tissue culture conditions to allow cells to migrate through the pores.
The inserts were removed, the medium changed and plates were placed back
in the incubator to expand the selected cell populations. The selection
process was repeated twice more as described above.
Independent small diameter MDAMB 231 flow cytometry-sorted (flow-
sorted; FS) populations were obtained by gating with low forward scatter
(FSC) and side scatter (SSC) parameters using a FACSAria Fusion sorter
(BD Biosciences, Oxford, UK). FS cells were grown using standard tissue
culture conditions to expand the isolated sorted cell populations, followed
by two additional rounds of sorting as described above.
Treatment of MDA MB 231 and MDA MB 435 cells with Trametinib
(Medchem Express, HY-10999) or U0126 (Cell Signalling Technology,
9903S) inhibitors were performed as follows. Cells were seeded in culture
dishes and grown overnight. Following incubation, 0.5 µM Trametinib or
10 µM U0126 was added and incubated for 24 h. After incubation, cells
were processed depending on the experimental requirements. Both drugs
were dissolved in DMSO (Sigma, D2650) to 10 mM stock concentrations.
Treatment of MDA MB 231 cells with cytochalasin D (Sigma, 8273) was
performed as follows. Cells were seeded in culture dishes and grown
overnight. On the next day, 0.5 µM cytochalasin D was added and incubated
for 2 h. After incubation, cells were processed depending on the
experimental requirements. Cytochalasin D was dissolved in DMSO to a
10 mM stock concentration.
Transwell cell migration assay
1.2×105 cells for 3-µm-pore membrane inserts (Corning, 3415) and 6×104
cells for 8-µm-pore membrane inserts (Corning, 4322) were re-suspended in
300 µl of serum-free medium. Cell suspensions were added into inserts and
placed in wells of 24-well plates containing 750 µl of serum-containing
medium. Plates were left for 3 days in standard culture conditions to allow
cells to migrate through membranes and attach to the lower chamber
compartment. The number of migrated cells at the bottom was quantified
using a sulforhodamine B (SRB) (Sigma, 230162) colorimetric assay. After
removing inserts, 10% (w/v) trichloroacetic acid (TCA) (Sigma, T6399) was
added to each well to reach a final concentration of 3.3%. The cells were
fixed at 4°C for 30 min. Cells were washed three times with water, air-dried
and 300 µl of 0.04% of SRB was added to each well and incubated for
30 min at room temperature. After incubation, SRB solution was removed,
wells were washed three times with 1% (v/v) acetic acid and air dried. Then,
250 µl of 10 mM Tris-HCl (pH 10.5) was added into each well and plates
were placed on a shaker for 15 min. After incubation, 200 µl from each well
was transferred to wells of 96-well plates and absorbance was measured on a
spectrophotometer at 490 nm. For each independent experiment, three
inserts were used per condition.
Cell and nuclear volume
Cell volumes (V ) were calculated using the formula V=¾πr3. Mean
diameter measurements were determined using a CASY® Cell Counter. For
each independent mean diameter determination, >5000 cells were counted
per replicate determination
Nuclei volumes were calculated using Volocity Software. Z-stack images
of DAPI-stained nuclei were taken on a Zeiss 710 confocal microscope. The
obtained z-stacks were analysed for 3D volumes using Volocity Software
(Quorum Technologies), with 32–74 nuclei measured per condition for each
independent experiment.
Morphological cell properties
To determine cell morphological features including cell and nuclear areas,
an Operetta high-content imaging system was used. Prior to cell imaging,
cells were seeded in black 96-well plates at 2×104 cells per well and
grown overnight. After incubation, cells were fixed with 4% (w/v)
Fig. 6. F-actin anisotropy, focal adhesion density, motility and cell
stiffness are influenced by MAPK activity. (A) Left panels, Sel2 MDA MB
231 cells were treated with DMSO or 0.5 µM Trametinib for 24 h, then stained
with phalloidin for F-actin. Scale bars: 10 µm. Middle panel, F-actin anisotropy
was scored for DMSO (n=70) and Trametinib (Tram; n=71) treatments.
****P<0.0001 (Student’s t-test). Right panel, relative mean±s.e.m. F-actin
integrated density normalized to levels for cells treated with DMSO vehicle.
DMSO, n=3; Trametinib, n=3 replicates. (B) Left panels, Sel1 MDA MB 435
cells were treated with DMSO or 0.5 µM Trametinib for 24 h, then stained with
phalloidin for F-actin. Scale bars: 10 µm. Middle panel, F-actin anisotropy was
scored for DMSO (n=85) and Trametinib (Tram; n=76) treatments.
****P<0.0001 (Student’s t-test). Right panel, relative mean±s.e.m. F-actin
integrated density normalized to levels for cells treated DMSO vehicle. DMSO,
n=3; Trametinib, n=3 replicates. (C) Left panels, Sel2 MDA MB 231 cells were
treated with DMSO or 0.5 µM Trametinib for 24 h, then stained for pFAK. Scale
bars: 10 µm. Right panel, mean±s.e.m. pFAK-positive focal adhesion density
was determined in three independent experiments for DMSO and Trametinib.
*P<0.05 (Student’s t-test). (D) Left panels, Sel1 MDA MB 435 cells were
treated with DMSO or 0.5 µM Trametinib for 24 h, then stained for pFAK. Scale
bars: 10 µm. Right panel; mean±s.e.m. pFAK-positive focal adhesion density
was determined in three independent experiments with DMSO and Trametinib
treatments. **P<0.01 (Student’s t-test). (E) Mean velocity of Sel2 MDAMB 231
cells was determined over 22 h in three independent experiments with, left
panel, DMSO vehicle or 0.5 µM Trametinib, or, right panel, DMSO or 10 µM
U0126 treatments. *P<0.05, ***P<0.001 (Student’s t-test). (F) Mean velocity of
Sel1 MDA MB 435 cells was determined over 22 h in three independent
experiments with, left panel, DMSO vehicle or 0.5 µM Trametinib, or, right
panel, DMSO or 10 µM U0126 treatments. ****P<0.0001 (Student’s t-test).
(G) Young’s modulus of Sel2 MDAMB 231 cells treated with, left panel, DMSO
vehicle (n=62) or 0.5 µM Trametinib (n=67), or, right panel, DMSO vehicle
(n=57) or 10 µM U0126 (n=65) for 24 h. ****P<0.0001 (Student’s t-test). (H)
Young’s modulus of Sel1 MDA MB 435 cells treated with, left panel, DMSO
vehicle (n=60) or 0.5 µM Trametinib (n=64), or, right panel, DMSO vehicle
(n=63) or 10 µM U0126 (n=68) for 24 h. ****P<0.0001 (Student’s t-test). For all
box plots, the box represents the 25–75th percentiles, and the median is
indicated. The whiskers show the 5–95th percentiles, and outliers are
indicated.
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Fig. 7. See next page for legend.
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paraformaldehyde (PFA; EMS, 15710) in PBS for 15 min and
permeabilized with 0.5% (v/v) Triton X-100 (Thermo Fisher Scientific,
28314) for 5 min at room temperature. Cells were incubated with 0.15 µg/ml
DAPI (Sigma, D9542) for 20 min at room temperature and subsequently
with 50 µl of 1:5000 dilution of Cellomics® Whole Cell Stain (WCS;
Thermo Fisher Scientific, 8303401) for 30 min. Plates were imaged on an
Operetta high-content imaging system and data was analysed using a
Columbus™ image data storage and analysis System (PerkinElmer).
Cytogenetic analysis of chromosome numbers
Metaphase spreads were produced by standard methods (Moralli et al.,
2011). Briefly, subconfluent cells were incubated in Colcemid
(Thermo Fisher Scientific) 30 ng/ml for 3 h, then cells were detached and
swelled in Buffered Hypotonic Solution (Genial Genetics) for 30 min.
Following two fixations in cold Carnoy’s fixative (methanol:acetic acid at
3:1), cell suspensions were dropped on slides. Cells were mounted in
Vectashield containing DAPI (Oncor) and analysed with an Olympus BX60
microscope for epifluorescence equipped with a Sensys CCD camera
(Photometrics). Images were collected and analysed using the Genus
Cytovision software (Leica). Chromosome numbers were counted in a
minimum of 20 cells per line. The analysis was repeated for a total of three
independent replicates.
3D collagen matrix invasion assay
Collagen matrix invasion assay was performed as described previously
(Rath et al., 2017). MEM/EBSS complete medium containing 10 µM
U0126 or DMSO was added to the dishes as indicated. Medium
was changed every other day. H&E-stained sections were scanned using
Leica Biosystems software (Leica). The invading distance of the cells
was measured using ImageJ software (NIH Image/ImageJ). For each
independent experiment, three or four collagen matrices were used
per condition.
RNA-Seq and qPCR
RNA-Seq and qPCR was performed as described previously (Rudzka
et al., 2017).
FLIM-FRET
H2B–GFP (fromAddgene vector 11680) andH2B–mCherry (fromAddgene
vector 20972), were introduced into MDA MB 231 cells by electroporation
using an Amaxa Cell Line Nucleofactor® Kit V (Lonza, VCA-1003). 2 µg of
DNA was introduced into cells according to manufacturer’s instructions.
Transfected cells were seeded on 35 mmglass-bottom dishes and left for 72 h
in standard tissue culture conditions. After incubation, cells were imaged
using FLIM microscopy. For 2-deoxyglucose (2-DG) and sodium azide
treatment, cells were treated with 50 mM 2-deoxyglucose (Sigma, D8375)
and 10 mM sodium azide (Sigma, S8032) 30 min before acquiring images.
Control cells were treated with H2O.
FLIM images were taken on a Nikon TE 2000 inverted microscope fitted
with a Lambert Instruments FLIM Attachment (LIFA) and a Yokogawa
CSU22 spinning disk unit with 100× objective. The microscope was
equipped with an incubation chamber suitable to maintain live cells and
optics at constant temperature. The LIFA system was equipped with an
Omicron 50 mW 445 nm laser for CFP lifetimes and a 60 mW 488 nm laser
for GFP lifetimes. The experiment is based on the frequency domain method
for fluorescence lifetime imaging and allows the rapid acquisition and
generation of lifetime images. Fluorescence lifetimes were measured using
LI-FLIM software (Lambert Instruments).
Plasma membrane fluidity determination using FRAP
2×105 cells were seeded on 35 mm glass-bottom dishes and incubated
overnight. After incubation, cells were washed twice with HBSS medium
followed by staining with NBD-sphingomyelin (Insight Biotechnology,
60031) at 4 µM for 10 min in room temperature protected from light. Cells
were rinsed and observed in HBSS medium (Thermo Fisher Scientific,
14065-049). Evaluation of membrane fluidity was obtained by measuring
lateral diffusion of NBD-sphingomyelin. All experiments were performed on
a Zeiss 880 confocal microscope with a 60× oil immersion objective was
used. For photobleaching, a 488 nm laser was used, set to 100% laser power.
Images were set to 510×200 pixels and speed 12 for sufficient speed
scanning. The zoom factor was set to 2 to avoid bleaching during acquisition.
For bleaching a region of interest (ROI1), a circle of 24 pixels was defined on
the apical cell body membrane. In order to perform quantification, two other
regions of interests were drawn around the cell (ROI2) and a random non-
fluorescent region, also referred to as background (ROI3). The mobile
fraction and50% fluorescent recovery (t1/2) were quantified usingEasy FRAP
software (omicX). The fluorescence intensity was normalized using a full-
scale normalization method. In order to extract quantitative information from
the curves, double-term fitting exponential equations were used.
Force indentation acquisition by AFM
Mechanical properties of individual cells were measured using an atomic
force microscope NanoWizard II (JPK Instruments) mounted onto an
inverted optical microscope (Zeiss Axio Observe) with a cell heater
attachment. Force indentation measurements were carried out using in-
house-prepared AFM colloidal probes (4.74 µm spherical silica bead
cantilevers, with a typical spring constant of ∼0.02 N/m) as described
previously (McPhee et al., 2010). Calibration measurements were
performed before every experiment to determine the spring constant for
each cantilever as described previously (Hutter and Bechhoefer, 1993).
Cells were cultured overnight prior to force indentation measurements.
During the experiment, cells were kept at 37°C and in 1% HEPES buffered
full medium to maintain pH levels. Indentations were performed at a loading
force of 3 nN and a constant speed of 2.5 µm/s. The Young’s modulus was
derived by fitting a force–distance curve with the Hertzian spherical model
(Lin et al., 2007). Five points on the central nucleus area of a cell were
measured, and the highest Young’s modulus value was used for the cell.
Comparative studies between different populations were conducted using
the same AFM probe and under the same conditions.
For transfections with GFP, GFP–KRas G12D (gift from Shehab Ismail,
CRUK Beatson Institute) and GFP–BRaf V600E (gift of Catrin Pritchard,
Fig. 7. Although MAPK inhibition does not alter cell size, increased MAPK
signalling alters actin organization and reduces cell stiffness. (A) Left,
mean±s.d. cell diameter profiles for Sel2 MDA MB 231 cells treated with
DMSO or 0.5 µM Trametinib for 24 h. Right, mean±s.e.m. cell profiles from
DMSO- or Trametinib-treated cells from three independent determinations.
(B) Left, mean±s.d. cell diameter profiles for Sel2MDAMB231 cells treated with
DMSO or 10 µM U0126 for 24 h. Right, mean±s.e.m. cell profiles from DMSO
or U0126 treated cells from three independent determinations. (C) Left, mean
±s.d. cell diameter profiles for Sel1 MDA MB 435 cells treated with DMSO
or 0.5 µM Trametinib for 24 h. Right, mean±s.e.m. cell profiles from DMSO- or
Trametinib-treated cells from three independent determinations. (D) Left, mean
±s.d. cell diameter profiles for Sel1 MDA MB 435 cells treated with DMSO
or 10 µM U1026 for 24 h. Right, mean±s.e.m. cell profiles from DMSO- or
U0126-treated cells from three independent determinations. Data for frequency
distributions in panels A–Dwere plotted at 0.1 µm bins. (E) Parent MDAMB 231
cells were transfected with plasmids encoding GFP or GFP–KRas G12D, and
enriched by flow sorting. Left panel, western blotting for GFP, pERK1/2 (red),
total ERK1/2 (green). Right panel; GFP–KRas G12D significantly increased
MAPK activation (ratio of pERK to total ERK). Results are mean±s.e.m. from
three independent experiments. *P<0.05 (Student’s t-test). (F) Parent MDA MB
231 cells transfected with plasmids encoding GFP or GFP–KRas G12D were
fixed and stained with phalloidin to reveal F-actin structures (left) or pFAK to
mark focal adhesions (middle). Scale bars: 20 µm. (G) Young’s modulus of cells
expressing GFP (n=60) or GFP-KRas G12D (n=61). **P<0.01 (Student’s t-test).
(H) Parent MDA MB 435 cells were transfected with plasmids encoding GFP or
GFP–BRaf V600E, and enriched by flow sorting. Left panel, western blotting for
GFP, active pERK1/2 (red) and total ERK1/2, (green). Right panel; GFP-BRaf
V660E significantly increased MAPK activation (ratio of pERK to total ERK).
Results are mean±s.e.m. from three independent experiments. **P<0.01
(Student’s t-test). (I) Parent MDA MB 435 cells transfected with plasmids
encoding GFP or GFP–BRaf V600E were fixed and stained with phalloidin to
reveal F-actin structures (left) or pFAK to mark focal adhesions (middle). Scale
bars: 20 µm. (J) Young’s modulus of GFP (n=61) or GFP-BRaf V600E (n=64)-
expressing cells. ****P<0.0001 (Student’s t-test). For all box plots, the box
represents the 25–75th percentiles, and the median is indicated. The whiskers
show the 5–95th percentiles, and outliers are indicated.
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University of Leicester, UK) (Hernandez et al., 2016), cells were plated at
5×104 per dish in 2 ml medium, and then transfected with FuGENE
(Promega) according to manufacturer’s instructions. After 5 h, medium
was changed and cells left overnight. Elasticity measurements were as
described above.
For the nuclei elasticity measurements, nuclei were isolated using the
Nuclei EZ Prep Nuclei Isolation kit (Sigma, NUC101) according to
manufacturer’s instructions. Isolated nuclei were seeded in 3 cm petri dishes
in the lysis buffer provided with the kit. Once nuclei had attached onto the
dish, AFM was performed as described above. One measurement was taken
per nucleus.
Immunofluorescence
Immunofluorescence images were taken on Zeiss 710 upright confocal
microscope or Zeiss 880 confocal using 63× oil immersion objectives.
Primary pFAK (pY397) (BD Bioscience, 611722) antibodies were
routinely used at 1:200 dilutions. Alexa Fluor 488-conjugated phalloidin
(Thermo Fisher Scientific, A12379), and Alexa Fluor 594 conjugated
(Thermo Fisher Scientific, A11032) secondary antibodies were used at
1:1000 dilution. Fluorescently labelled cells were mounted with ProLong
Diamond including DAPI (Thermo Fisher Scientific, P36961).
Cellswere fixedwith 4% (w/v) PFA inPBS at room temperature for 15 min.
Cells were permeabilized with 0.5% (v/v) Triton X-100 in PBS for 5 min at
room temperature and non-specific binding was blocked with 1% BSA in
PBS for 30 min at room temperature. Primary antibodies were incubated for
2 h at room temperature while secondary antibodies were incubated for 1 h at
room temperature.
TIRF microscopy and F-actin anisotropy
TIRF images were taken on a Nikon Eclipse TE2000-U microscope. A
100×1.45 NA Plan Apochromat TIRF oil objective (Nikon) was used. The
microscope was equipped with a Photometrics Evolve 512 camera, which
allowed illumination of GFP and RFP at 473 nm and 561 nm, respectively.
Red and green fluorescence signals were separated using a DualView DV2
emission splitter. MetaMorph software was used to control camera shutters
and light source. Samples for imaging were prepared as described for
immunofluorescence. In order to quantify F-actin anisotropy, the ImageJ
plugin FibrilTool was used (Boudaoud et al., 2014).
Scanning electron microscopy
Isolated nuclei were seeded on 10 mm coverslips placed in 24-well plates
and cultured overnight. After incubation, they were fixed with 3%
glutaraldehyde in 0.1 M phosphate buffer for 2 h at room temperature.
After fixation, nuclei were washed three times with 0.1 M phosphate buffer
for 10 min each. Scanning electron microscopy was performed as described
previously (Wickman et al., 2013).
Imaging cell projections into microporous membranes
Cells grown on membrane filters were washed in PBS before fixing in 1.5%
glutaraldehyde/0.1 M sodium cacodylate buffer for 1 h at 4°C then washed
three times for 5 min each in 0.1 M sodium cacodylate buffer containing 2%
(w/v) sucrose. Samples were post-fixed in 1% osmium tetroxide/0.1 M
sodium cacodylate buffer for 1 h, then washed three times for 10 min each
time in distilled water followed by en block staining in 0.5% aqueous uranyl
acetate for 1 h (in dark–light-sensitive stain) and washed again twice
for 1 min with distilled water. Dehydration steps were through a graded
ethanol series (30%, 50%, 70% and 90%) for 10 min each, then 100%
ethanol four times for 5 min each time, followed with propylene oxide three
times for 5 min each time, and then 1:1 propylene oxide:Araldite/Epon resin
(TAAB 812) overnight. Samples were then put into fresh pure Epon/Araldite
resin, embedded in flat-bed moulds and polymerized for 48 h at 60°C.
Light microscope semi-thin sections (350 nm) were cut using a LEICA
Ultracut UCT (Leica Microsystems) and Diatome diamond Histo-knife
(Diatome) at an angle of 6°. Sections floating on water were stretched with
chloroform vapour, picked up using a wire loop placed onto a droplet of
distilled water and dried on a glass slide, using a hotplate set at 80°C.
Sections were stained for 15–30 s with 1% Toluidine Blue stain, washed
with 1% Borax with fresh distilled water and left to dry before mounting
with a glass coverslip using DPX.
Transfection, cell sorting and immunoblotting
To transfect ParentMDAMB 231 orMDAMB 435 cells, they were initially
plated at 1.5×106 cells per 10 cm diameter plate. For each GFP expression
plasmid, 10 μg DNA was diluted into 500 µl jetPRIME® buffer (Polyplus,
114-07) and mixed by vortexing; then 20 μl jetPRIME® was added, mixed
by vortexing, and plates were incubated for 10 min at room temperature. The
transfection mix was added drop-wise onto cells in each plate with serum-
containing medium, and distributed evenly by gentle rocking. Medium was
replaced 4 h later with complete medium, and then cells were incubated
overnight. Cells in each conditioned were trypsinized and pooled at a final
concentration of 106 cells/ml in medium with 1% FBS, and sorted for green
fluorescence using a BD FACSAria™ with a 100 µm nozzle at 20 psi.
Standard protocols were used for western blot analysis as described
previoulsy (Rath et al., 2017). Whole-cell lysates were prepared in cell lysis
buffer (1% SDS, 50 mM Tris-HCl pH 7.5 plus protease inhibitors), and
protein concentrations were determined by performing a Bicinchoninic
assay (Sigma, B9643). Primary antibodies were routinely used at 1:1000
dilutions. Primary antibodies used were against GFP (Abcam, ab6556),
pERK (Cell Signaling Technology, 9106), ERK (Cell Signaling
Technology, 9102). Secondary antibodies used were goat anti-rabbit IgG
(H+L) highly cross-adsorbed antibody conjugated to Alexa Fluor 680
(Thermo Fisher Scientific; A21109), goat anti-mouse IgG (H+L) highly
cross-adsorbed antibody conjugated to Alexa Fluor 680 (Thermo Fisher
Scientific; A21058) and IR Dye 800CW- conjugated donkey anti-rabbit-
IgG (LICOR; 925-32213) at 1:5000 dilutions, and were detected by infrared
imaging (Li-Cor Odyssey CLx).
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S., Rimokh, R., Sergent, O., Penna, A. et al. (2015). Downregulation of ceramide
synthase-6 during epithelial-to-mesenchymal transition reduces plasma
membrane fluidity and cancer cell motility. Oncogene 34, 996-1005. doi:10.
1038/onc.2014.55
Erdogan, B. and Webb, D. J. (2017). Cancer-associated fibroblasts modulate
growth factor signaling and extracellular matrix remodeling to regulate tumor
metastasis. Biochem. Soc. Trans. 45, 229-236. doi:10.1042/BST20160387
Faria, E. C., Ma, N., Gazi, E., Gardner, P., Brown, M., Clarke, N. W. and Snook,
R. D. (2008). Measurement of elastic properties of prostate cancer cells using
AFM. Analyst 133, 1498-1500. doi:10.1039/b803355b
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A.,
Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F. et al. (1998).
Identification of a novel inhibitor of mitogen-activated protein kinase kinase.
J. Biol. Chem. 273, 18623-18632. doi:10.1074/jbc.273.29.18623
Furusawa, T., Rochman, M., Taher, L., Dimitriadis, E. K., Nagashima, K.,
Anderson, S. and Bustin, M. (2015). Chromatin decompaction by the
nucleosomal binding protein HMGN5 impairs nuclear sturdiness. Nat. Commun.
6, 6138. doi:10.1038/ncomms7138
Gillooly, J. F., Hein, A. and Damiani, R. (2015). Nuclear DNA content varies with
cell size across human cell types. Cold Spring Harb. Perspect. Biol. 7, a019091.
doi:10.1101/cshperspect.a019091
Grimaldi, A. M., Simeone, E., Festino, L., Vanella, V., Strudel, M. and Ascierto,
P. A. (2017). MEK inhibitors in the treatment of metastatic melanoma and solid
tumors. Am. J. Clin. Dermatol. 18, 745-754. doi:10.1007/s40257-017-0292-y
Gritsenko, P. G., Ilina, O. and Friedl, P. (2012). Interstitial guidance of cancer
invasion. J. Pathol. 226, 185-199. doi:10.1002/path.3031
Gupta, M., Sarangi, B. R., Deschamps, J., Nematbakhsh, Y., Callan-Jones, A.,
Margadant, F., Meg̀e, R.-M., Lim, C. T., Voituriez, R. and Ladoux, B. (2015).
Adaptive rheology and ordering of cell cytoskeleton govern matrix rigidity sensing.
Nat. Commun. 6, 7525. doi:10.1038/ncomms8525
Gupta, M., Doss, B., Lim, C. T., Voituriez, R. and Ladoux, B. (2016). Single cell
rigidity sensing: a complex relationship between focal adhesion dynamics and
large-scale actin cytoskeleton remodeling. Cell Adh. Migr. 10, 554-567. doi:10.
1080/19336918.2016.1173800
Hayashi, K. and Iwata, M. (2015). Stiffness of cancer cells measured with an AFM
indentation method. J. Mech. Behav. Biomed. Mater. 49, 105-111. doi:10.1016/j.
jmbbm.2015.04.030
Hernandez, M. A., Patel, B., Hey, F., Giblett, S., Davis, H. and Pritchard, C.
(2016). Regulation of BRAF protein stability by a negative feedback loop involving
the MEK-ERK pathway but not the FBXW7 tumour suppressor. Cell. Signal. 28,
561-571. doi:10.1016/j.cellsig.2016.02.009
Hutter, J. L. and Bechhoefer, J. (1993). Calibration of atomic-force microscope
tips. Rev. Sci. Instrum. 64, 1868-1873. doi:10.1063/1.1143970
Jenkins, D. E., Hornig, Y. S., Oei, Y., Dusich, J. and Purchio, T. (2005).
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in
vivo detection of mammary tumors and multiple metastases in immune deficient
mice. Breast Cancer Res. 7, R444-R454. doi:10.1186/bcr1026
Kuznetsova, T. G., Starodubtseva, M. N., Yegorenkov, N. I., Chizhik, S. A. and
Zhdanov, R. I. (2007). Atomic force microscopy probing of cell elasticity. Micron
38, 824-833. doi:10.1016/j.micron.2007.06.011
Levy, D. L. and Heald, R. (2012). Mechanisms of intracellular scaling. Annu. Rev.
Cell Dev. Biol. 28, 113-135. doi:10.1146/annurev-cellbio-092910-154158
Li, Q. S., Lee, G. Y. H., Ong, C. N. and Lim, C. T. (2008). AFM indentation study of
breast cancer cells. Biochem. Biophys. Res. Commun. 374, 609-613. doi:10.
1016/j.bbrc.2008.07.078
Lin, D. C., Dimitriadis, E. K. and Horkay, F. (2007). Robust strategies for
automated AFM force curve analysis-II: adhesion-influenced indentation of soft,
elastic materials. J. Biomech. Eng. 129, 904-912. doi:10.1115/1.2800826
Litzenburger, U. M., Buenrostro, J. D., Wu, B., Shen, Y., Sheffield, N. C.,
Kathiria, A., Greenleaf, W. J. and Chang, H. Y. (2017). Single-cell epigenomic
variability reveals functional cancer heterogeneity. Genome Biol. 18, 15. doi:10.
1186/s13059-016-1133-7
Ller̀es, D., James, J., Swift, S., Norman, D. G. and Lamond, A. I. (2009).
Quantitative analysis of chromatin compaction in living cells using FLIM-FRET.
J. Cell. Biol. 187, 481-496. doi:10.1083/jcb.200907029
Lugassy, C., Zadran, S., Bentolila, L. A., Wadehra, M., Prakash, R., Carmichael,
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